Evolving trends in pediatric thyroid nodules and cancer management
Annals of Pediatric Endocrinology & Metabolism · 30.06.2026 · 31 (3) · 149-159
DOI: 10.6065/apem.2550420.210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pediatric Endocrinology & Metabolism, erschienen am 30.06.2026. Verfasst von Sabitha Sasidharan Pillai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Endocrinology, Diabetes & Metabolism, Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of So…. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Differentiated thyroid cancer (DTC) is the most common form of pediatric thyroid cancer, yet its management has been largely based on evidence from adults. Recent advances in science and clinical studies of pediatric DTC, particularly in papillary thyroid carcinoma, the predominant subtype, now form the basis of emerging paradigms and revised guidelines. The potential of malignancy in thyroid nodules, as defined by current ultrasound risk stratification systems, has been evaluated in pediatric patients, enabling evidence-based indication for fine-needle aspiration biopsy. Observational studies comparing the effect of different interventions on prognosis, complications, and quality of life, challenge traditional surgical approaches in favor of potentially less extensive initial resection. Recognition of distinct underlying oncogenic drivers has not only paved the way for discoveries in the biology of pediatric thyroid cancer but has also advanced the era of targeted systemic therapy for progressive and metastatic pediatric DTC. Certain genome alterations, particularly oncogenic gene fusions that are more common in pediatric DTC, can now be targeted with small-molecule inhibitors, offering more effective therapy for metastatic disease with fewer and less severe adverse effects. This review offers an evidence-based summary of these data and the evolving trends in the diagnosis and management of pediatric DTC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Endocrinology, Diabetes & Metabolism, Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Division of Endocrinology and Diabetes, Keck School of Medicine of USC, Los Angeles, CA, USA. trevor.angell@med.usc.edu.
Zitieren
APA
Pillai, S. S., Austin, J., & Angell, T. E. (2026). Evolving trends in pediatric thyroid nodules and cancer management. Annals of Pediatric Endocrinology & Metabolism, 31(3), 149-159. https://doi.org/10.6065/apem.2550420.210
Vancouver
Pillai SS, Austin J, Angell TE. Evolving trends in pediatric thyroid nodules and cancer management. Annals of Pediatric Endocrinology & Metabolism. 2026;31(3):149-159. doi:10.6065/apem.2550420.210
BibTeX
@article{Pillai2026,
author = {Pillai, Sabitha Sasidharan and Austin, Juliana and Angell, Trevor E},
title = {Evolving trends in pediatric thyroid nodules and cancer management},
journal = {Annals of Pediatric Endocrinology & Metabolism},
year = {2026},
volume = {31},
number = {3},
pages = {149--159},
doi = {10.6065/apem.2550420.210}
}
EUVIMED